EMILY WESTON: Open Payments
NPI 1366098881 · MIFFLINBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 21 payments from 11 companies in 2025. Trend: 2023 $1,065 · 2024 $592 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| ABBVIE INC. | 3 | $61 |
| Verona Pharma, Inc. | 2 | $60 |
| PFIZER INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $35 |
| Dexcom, Inc. | 2 | $30 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VOQUEZNA, Ohtuvayre, ELIQUIS, Dexcom G6 Transmitter, UBRELVY, Filspari, KISUNLA, QULIPTA.
Industry payments across PA — which companies pay providers there.
